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ABSTRACT
Selected and basic indicators of acute ischaemic stroke care in Poland are reported cross-regionally based on the analysis of claims data 
of the National Health Fund (NFZ) in 2017, the most reliable source of healthcare funding in the country, being a single public payer. 
For research purposes, a selection algorithm based on the diagnosis coded as I63 according to the International Classification of 
Diseases (ICD-10) was used to identify all ischaemic stroke patients in the claims database provided by the NFZ. Stroke units and 
other centres providing treatment for acute ischaemic stroke patients were examined. The analysis showed marked differences 
between provinces in terms of stroke unit treatment availability. The crude and standardised rates of acute ischaemic stroke 
admissions to stroke units varied between provinces. Moreover, substantial differences were observed for the thrombolysis im-
plementation rate, access to rehabilitation, hospital stay and early prognosis. As the leading cause of disability and the second 
leading cause of death in developed countries, stroke requires a well-organised, evidence-based healthcare system provided 
for both acute treatment and rehabilitation. Continuous monitoring of healthcare is crucial to identify weaknesses and areas 
for improvement.
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Background
Being the second greatest cause of death in developed 
countries, and the leading cause of complex permanent dis-
ability, stroke requires well-organised and evidence-based 
healthcare for both acute treatment and rehabilitation [1]. 
A comprehensive and equally distributed system of stroke 
care delivery is needed to manage emergency services, acute 
care in stroke units, and to provide rehabilitation. Continu-
ous monitoring of healthcare quality indicators in reference 
to changing epidemiological data is crucial to identify any 
weaknesses and areas for improvement.
Evidence-based treatment of ischaemic stroke includes, 
broadly, management in stroke units (defined as an organised 
in-hospital facility entirely devoted to caring for patients with 
stroke and staffed by a multidisciplinary team with specialist 
knowledge and experience carrying out stroke-specific and 
general care procedures), recanalisation and reperfusion (ei-
ther thrombolysis or thrombectomy, or both), aspirin for early 
recurrence prevention, and decompressive craniectomy [2, 3]. 
Moreover, early prevention and rehabilitation are beneficial 
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for the treatment process, and therefore require quick and 
appropriate application.
The first Polish population-based study showed stroke 
mortality failed to decline between 1984 and 1992, with 
neither case fatality nor stroke incidence declining [4]. As 
a consequence, national programmes to improve stroke 
care were implemented. Both the National Programme 
for Stroke Prevention and Treatment and the subsequent 
National Programme for Prevention and Treatment of Car-
diovascular Diseases (POLKARD) were mainly focused on 
supporting stroke units and evidence-based stroke care. Both 
programmes monitored selected indicators of acute stroke 
care, although reporting data to a stroke registry was not 
mandatory [5, 6]. Registry-based studies demonstrated sig-
nificant differences in patient characteristics, acute hospital 
care, and outcomes among participating centres [7] as well 
as the so called ‘weekend effect’. Such differences can result 
from not only stroke severity but also stroke care quality 
and organisation [8].
Improvement in stroke risk and prognosis was first re-
ported by a study comparing data from the Warsaw Stroke 
Registry (1992) and the European Register of Stroke (2005). 
Although incidence rates did not change, early (30-day) and 
late (1-year) case fatality decreased significantly, from 43% to 
14.9% and from 59.7% to 33.1% respectively [9].
Some projects were also implemented at a regional level, 
and mostly reported similar findings [10–13].
All of these initiatives had limited national representa-
tiveness until the 2008 Hospital Stroke Registry initiation 
brought about mandatory reporting on stroke patients 
admitted to hospital. Data for 2009–2013 showed a slow 
improvement in in-hospital survival [14]. Unfortunately, 
even the 2008 Hospital Stroke Registry collected only lim-
ited and basic information, that moreover was not reported 
systematically and remained unverified. There has been 
no recent robust, comprehensive and representative data 
on acute stroke care, nor in particular data combining the 
use of recanalisation/reperfusion interventions and early 
rehabilitation.
Diagnosis related groups were introduced in 2008 to 
provide principal diagnosis-orientated hospital care funding 
in Poland. The Maps of Healthcare Needs (MPZ) project was 
aimed at analysing data collected by public institutions to iden-
tify current clinical practice and healthcare service provision, 
and also to specify prognosis for healthcare and to implement 
continuous monitoring. This was the first comprehensive 
approach to monitoring healthcare systematically across 
different therapeutic areas and covering the entire system in 
both hospital and outpatient settings.
The objective of this paper was to illustrate acute ischaemic 
stroke care in various provinces of Poland based on the data 
reported by hospitals to the National Health Fund (NFZ), as 
well as information collected by the Central Statistical Office 
and Department of National Central Evidences run by the 
Ministry of Internal Affairs and Administration in 2017 and 
pooled within the MPZ project.
Methods
A selection algorithm based on the diagnosis coded as 
I63 according to the International Classification of Dis-
eases (ICD-10) was used to identify all ischaemic stroke 
patients in the database of hospital healthcare services 
covered by the NFZ. Additionally, early survival of pa-
tients could be tracked using their national identification 
number (PESEL).
Stroke patients’ rates were presented as crude numbers 
and values standardised by age and gender for each of 16 ad-
ministrative provinces. Stroke hospital admission rates were 
presented as numbers per 100,000 inhabitants.
Stroke units providing treatment for acute ischaemic stroke 
patients were explored. Stroke units were identified not only 
as registered in the Central Register of Healthcare Centres but 
additionally as centres reporting specific dedicated DRG codes 
(A48 — comprehensive treatment of stroke patients in stroke 
units lasting longer than seven days, and A51 — thrombolytic 
therapy of patients treated in stroke units for longer than seven 
days). Given that these DRG codes specific to stroke units 
can be reported for patients hospitalised for 7+ days only, the 
analysis also included other stroke-related DRG codes for all 
healthcare service centres.
Thrombolysis rates were calculated based on the reported 
number of procedures of thrombolysis (ICD-9 code: 99.102 – in-
travenous infusion of second-generation thrombolytic agent – 
and related specific codes 99.101, 99.103, 99.104) for all 
admitted ischaemic stroke patients and presented separately 
for each province. In addition, we reported the number of 
stroke centres delivering thrombolysis, the number of stroke 
units with thrombolysis rates of over 10%, and the corre-
sponding rates of patients hospitalised in these centres across 
all provinces. Corresponding data was calculated for acute 
rehabilitation reported within 30 days of stroke onset during 
the initial hospital stay.
‘Hospital stay’ was calculated as the difference between the 
admission date and the discharge or in-hospital death date, and 
presented as a median for each province and range between 
in-province centres with the lowest and highest median values 
of length of stay.
Early mortality rate was calculated for 10 days, 30 days and 
90 days starting from hospital admission, and was adjusted 
for age and sex.
Statistical analysis
Descriptive statistics were presented for the entire country and 
each province. Standardisation was made for the European pop-
ulation [15]. In-hospital and early mortality rates were presented 
as crude mean values and additionally adjusted for age and sex.
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Dolnośląskie 2902,365 5,684 72.21 50.14 11 11 9 77.67
Kujawsko-
-Pomorskie
2082,935 4,008 73.26 51.49 10 8 6 97.38
Lubelskie 2129,260 4,365 73.80 49.48 14 8 7 89.64
Lubuskie 1016,652 2,555 72.30 52.67 5 4 3 88.67
Łódzkie 2479,962 5,391 71.45 50.35 11 10 7 65.07
Małopolskie 3386,162 6,105 72.03 51.02 15 14 10 85.96
Mazowieckie 5372,579 9,589 72.50 50.25 24 20 15 90.87
Opolskie 991,161 2,109 74.02 54.80 3 3 2 93.66
Podkarpackie 2127,687 4,208 73.29 50.01 16 11 2 90.40
Podlaskie 1185,174 2,155 73.89 49.20 4 4 3 79.77
Pomorskie 2319,735 4,578 71.81 48.23 11 9 8 96.78
Śląskie 4552,627 10,007 72.68 48.62 24 21 15 86.95
Świętokrzyskie 1249,710 2,905 73.22 48.06 7 7 3 97.14
Warmińsko-
-Mazurskie
1434,783 2,849 72.91 52.00 7 6 4 75.55
Wielkopolskie 3484,975 6,625 70.97 46.15 12 12 9 73.14
Zachodniopo-
morskie
1706,579 3,194 71.38 45.43 7 7 5 90.75
Poland 38422,346 76,327 72.29 49.42 181 155 108 85.66
Results
The total number of ischaemic stroke hospital admissions 
in 2017 amounted to 76,327 and was reported for a total of 
72,983 patients with a mean age of 72.29 years (the age of 34.8% 
of patients was 80 or older). The great majority of patients 
were managed in stroke units (85.66%), while the remaining 
patients were admitted to neurological wards with no stroke 
units (7%), or to general wards (10%) or to other departments. 
Considerable differences were found between provinces in 
terms of stroke unit treatment availability, with less than two 
thirds of patients hospitalised in the Łódzkie (65.1%) province, 
but virtually all patients in the Świętokrzyskie, Pomorskie and 
Kujawsko-Pomorskie provinces. In most provinces, stroke unit 
care was provided by high-volume centres (over 200 admitted 
patients) except for Mazowieckie, Śląskie, Podkarpackie and 
Lubelskie provinces, in which several centres provided care for 
a lower number of ischaemic stroke patients (Tab. 1).
The crude and standardised rates of acute ischaemic stroke 
admission varied considerably between the different prov-
inces, from 169.34 to 236.95 and from 109.32 to 169.49 per 
100,000 inhabitants, respectively (Tab. 2). The mean values for 
the entire country were 189.95 and 130.43 per 100,000 inhabit-
ants, respectively.
Substantial differences were observed for the thrombolysis 
implementation rate. While there were provinces that reported 
its use for 7% of ischaemic stroke patients only, there were also 
provinces that reported it twice as often (Tab. 3). A similar 
discrepancy was observed for admission to centres reporting 
thrombolysis. In the Kujawko-Pomorskie, Świętokrzyskie 
and Pomorskie provinces, virtually all (99%) stroke patients 
were hospitalised in centres offering thrombolysis, while that 
figure was only 65% in the Łódzkie province. In general, 14% 
of Polish stroke patients were still hospitalised in a centre 
which reported no thrombolysis treatment. The correspond-
ing percentage of patients hospitalised in centres with a high 
thrombolysis rate (over 10%) was 67.54% and varied from 
39.45 to 90.82%.
Providing rehabilitation within 30 days of stroke onset 
was declared for 31.61% of patients, and ranged from 25.03% 
(Lubelskie province) to 37.73% (Śląskie province).
The variability of the median length of stay was more 
intra-province than inter-province (i.e. there were differences 
between centres in the same province with the lowest and 
highest median values).
Comparing patients’ permanent residences to the locations 
where stroke healthcare was provided revealed a transfer rate 
of only 5%.
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Table 2. Ischaemic stroke hospital admission data (rate per 100,000 inhabitants — 2017)
Province Crude ischaemic  
stroke patients  
rates
Standardised ischaemic 
stroke patients rates 
(95% CI)
Lower limit Upper limit Hospital admission 
rates for general po-
pulation
Dolnośląskie 185.92 122.0264 118.7705 125.2824 195.84
Kujawsko-Pomorskie 186.61 130.9012 126.7860 135.0164 192.42
Lubelskie 197.72 125.5782 121.7848 129.3716 205.00
Lubuskie 236.95 169.4932 162.7247 176.2616 251.32
Łódzkie 210.20 130.4038 126.8638 133.9438 217.38
Matopolskie 169.34 116.5921 113.5742 119.6099 180.29
Mazowieckie 171.74 113.3548 111.0419 115.6678 178.48
Opolskie 203.80 130.1942 124.5165 135.8719 212.78
Podkarpackie 190.02 131.6283 127.5708 135.6858 197.77
Podlaskie 174.74 109.3261 104.6175 114.0347 181.83
Pomorskie 189.03 137.1924 133.1317 141.2531 197.35
Śląskie 211.13 136.1516 133.4297 138.8735 219.81
Świętokrzyskie 223.97 138.5972 133.4626 143.7318 232.45
Warmińsko-Mazurskie 189.85 139.3403 134.1075 144.5730 198.57
Wielkopolskie 180.66 133.3310 130.0375 136.6244 190.10
Zachodniopomorskie 181.24 122.7501 118.4241 127.0761 187.16
Poland 189.95 130.4288 126.3027 134.5549 198.65
Note: Columns 3, 4. 5: Age-standardised admission rates per 100,000 inhabitants for all ages up to 90+ using the 2013 European Standard Population (ESP)
Table 3. Thrombolysis in Poland — 2017













bolysis rate over 
10%
Percentage of all acute ischa-
emic stroke patients hospi-
talised in  
centres reporting over 10% 
thrombolysis rate
Dolnośląskie 12.24 11 77.67 9 71.38
Kujawsko-Pomorskie 15.59 10 97.38 8 81.49
Lubelskie 11.84 14 89.64 9 58.10
Lubuskie 9.43 5 88.67 1 39.45
Łódzkie 11.91 10 65.07 8 52.05
Matopolskie 12.33 15 85.96 13 78.51
Mazowieckie 13.34 24 90.87 19 73.28
Opolskie 14.22 3 93.66 2 78.36
Podkarpackie 17.78 15 90.40 15 90.82
Podlaskie 6.87 4 79.77 2 33.07
Pomorskie 15.29 11 96.78 10 86.49
Śląskie 11.83 26 86.95 17 61.08
Świętokrzyskie 14.63 7 97.14 5 75.34
Warmińsko-Mazurskie 11.58 7 75.55 7 74.92
Wielkopolskie 12.75 12 73.14 8 51.61
Zachodniopomorskie 13.81 7 90.75 5 64.73
Poland 12.94 181 85.66 138 67.54
Note: ICD-9 codes of thrombolysis: 99.10, 99.101, 99.102, 99.103 99.104
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Finally, the 30-day and 90-day adjusted mortality rates varied 
between provinces, from 14.42% (Pomorskie province) to 23.48% 
(Podlaskie province), and from 20.23% (Kujawsko-Pomorskie 
province) to 26.02% (Podlaskie province), respectively (Tab. 4).
Discussion
Over the last decade, the standard of stroke care in Poland 
has markedly improved, mainly due to the development of 
a network of stroke units. Most recent studies, both national 
and regional, have reported decreasing early and late fatality 
rates as well as lower admission rates, not only for first-ever 
but also recurrent strokes [14, 16, 17]. 
However, variations in selected indicators of acute ischae-
mic stroke care and outcomes across all Polish provinces are 
still common. Epidemiological, geographical and infrastruc-
tural differences across the country can explain some of these 
variations, but they are mostly caused by differences in local 
care organisation, with extensive room for improvement in 
multiple indicators that are linked to the functional outcome 
of stroke victims such as the rate of patients treated at stroke 
units, the rate of thrombolysis, or the availability of rehabilita-
tion. Hospital practices and early prognosis require corrections 
and then further long-term monitoring and analysis, in the 
context of local interpretation and undertakings. 
It is vital to propose optimal acute stroke care to facilitate 
early access not only to thrombolysis but also thrombectomy 
effective for selected stroke patients. Invasive (endovascular) 
treatment of ischaemic stroke was beyond the scope of this 
analysis, because at that time it was not funded from public 
sources, and performed only in a few hospitals in the country. 
Further studies should take this issue into account. 
The high ischaemic stroke in-hospital admission rate, of 
over 198.65 per 100,000 population, could be slightly inflated 
by misreporting and overclaiming for that diagnosis. But even 
taking that into account, it clearly indicated increased stroke 
incidence compared to previous epidemiological studies [18]. 
It is worth noting that this analysis included only hos-
pital admission due to acute stroke, which means that all 
pre-hospital case fatalities and potential outpatient acute 
ischaemic stroke management were ignored. However, 
given the organisation of the Polish healthcare system, it 
is unlikely that the latter would change the results signifi-
cantly. Nevertheless, this analysis should not be perceived 
as an epidemiological study with case ascertainment and an 
overlapping source of data.
The great majority (almost 86%) of stroke patients in Po-
land are treated in stroke units. Unfortunately, 17% of stroke 
unit patients are hospitalised for up to seven days (data not 
presented) and could not be reported with DRG codes specific 
to the individual stroke unit. As a consequence, treatment for 
a considerable number of patients in stroke units is financed 
in the same manner as in non-stroke units. This can result 
in unnecessarily prolonged hospital stays for minor stroke 
patients in Polish stroke units.
The thrombolysis rate is often regarded as one of the most 
important indicators of acute stroke care quality [19]. In Po-
land, this overall rate is lower than in many European Union 
countries, although it is much higher than in most countries 
in the world [20]. A survey conducted in 44 European coun-
tries in 2016/2017 showed a low thrombolysis rate in Poland 
[21]. Since then, it has increased substantially, yet unevenly 
as reported in our study. 
Early ischaemic stroke mortality remains quite high in 
Poland compared to other European countries, and this will 
require special consideration and resources to overcome [22]. 
Unfortunately, no Polish official databases include modified 
Rankin scale results, which might provide more robust infor-
mation on the general care of stroke patients than the mortality 
figure alone. Nevertheless, the differences in ischaemic stroke 
hospital admissions, as well as early and late stroke outcomes, 
are unlikely to result only from differences in comorbidities 
and demographics.
Limitations
A retrospective design and the analysis of data collected for 
financial rather than clinical or research purposes are the main 
limitations of this study. Therefore, the analyses were restricted to 
only those most likely to be unaffected by reporting bias. Poland as 
a country forms a single public payer for healthcare, which makes 
claims data highly comprehensive. Consequently, cross-regional 
analysis could be affected by patients being transferred between 
neighbouring provinces. The places is residence of patients and 
the locations in which healthcare was provided were analysed, 
and it was discovered that a transfer rate is only 5%.
In-hospital mortality rates were reported but not interpreted 
because they could have been affected by acute stroke care organ-
isation, e.g. early discharge in centres with facilitated access or 
on-site rehabilitation units. Therefore, the research concentrated 
on 10-, 30- and 90-day mortality rates, for which data is complete.
Funding: This study was based on the project ‘Maps of Health 
Needs – Database of Systemic and Implementation Analyses’ 
co-financed by the European Union from the European Social 
Fund as part of the Operational Programme Knowledge Edu-
cation Development. The National Health Fund data reported 
in Poland was evaluated. The authors of this study report no 
conflict of interest. The approval of bioethical committees was 
not required.
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